BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2006) 79, 331-335
© 2006 British Institute of Radiology
doi: 10.1259/bjr/16208090

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, D S
Right arrow Articles by Dinshaw, K A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, D S
Right arrow Articles by Dinshaw, K A

Full Paper

Peripheral dose from uniform dynamic multileaf collimation fields: implications for sliding window intensity-modulated radiotherapy

D S Sharma, MSc, DipRP1, Animesh, MSc, DipRP2, S S Deshpande, MSc, DipRP1, R D Phurailatpam, MSc, DipRP3, D D Deshpande, PhD1, S K Shrivastava, MD4 and K A Dinshaw, FRCR4

Departments of 1 Medical Physics and 4 Radiation Oncology, Tata Memorial Hospital, Dr. Ernest Borges Marg, Parel, Mumbai, 400 012, India, 2 Kirloskar Theratronics, Mumbai and 3 Clinical Research Centre, ACTREC, New Mumbai, India


    Abstract
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 References
 
The increase in the number of monitor units in sliding window intensity-modulated radiotherapy, compared with conventional techniques for the same target dose, may lead to an increase in peripheral dose (PD). PD from a linear accelerator was measured for 6 MV X-ray using 0.6 cm3 ionization chamber inserted at 5 cm depth into a 35 cm x 35 cm x 105 cm plastic water phantom. Measurements were made for field sizes of 6 cm x 6 cm, 10 cm x 10 cm and 14 cm x 14 cm, shaped in both static and dynamic multileaf collimation (DMLC) mode, employing strip fields of fixed width 0.5 cm, 1.0 cm, 1.5 cm, and 2.0 cm, respectively. The effect of collimator rotation and depth of measurement on peripheral dose was investigated for 10 cm x 10 cm field. Dynamic fields require 2 to 14 times the number of monitor units than does a static open field for the same dose at the isocentre, depending on strip field width and field size. Peripheral dose resulting from dynamic fields manifests two distinct regions showing a crest and trough within 30 cm from the field edge and a steady exponential fall beyond 30 cm. All dynamic fields were found to deliver a higher PD compared with the corresponding static open fields, being highest for smallest strip field width and largest field size; also, the percentage increase observed was highest at the largest out-of-field distance. For 6 cm x 6 cm field, dynamic fields with 0.5 cm and 2 cm strip field width deliver PDs 8 and 2 times higher than that of the static open field. The corresponding factors for 14 cm x 14 cm field were 15 and 6, respectively. The factors by which PD for DMLC fields increase, relative to jaws-shaped static fields for out-of-field distance beyond 30 cm, are almost the same as the corresponding increases in the number of monitor units. Reductions of 20% and 40% in PD were observed when the measurements were done at a depth of 10 cm and 15 cm, respectively. When the multileaf collimator executes in-plane (collimator 90°) motion, peripheral dose decreases by as much as a factor of 3 compared with cross-plane data. The knowledge of PD from DMLC field is necessary to estimate the increase in whole-body dose and the likelihood of radiation induced secondary malignancy.


    Introduction
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 References
 
Absorbed dose outside the primary radiation field (peripheral dose; PD) is of clinical interest in estimating out-of-field organ dose and subsequent long-term radiation sequelae. Potential effects of PD such as cataract formation, gonadal dysfunction and infertility, and damage to fetus, and their threshold doses, have been summarized by Fraass and van de Geijn [1]. The potential damage to the fetus from PD sometimes creates clinical dilemmas during decision making in radiation therapy of pregnant patients [24].

Prior investigators have confirmed that increase in the number of monitor units (MU) in tomotherapy, compared with a conventional technique for the same tumour dose, results in a higher whole-body dose [57]. For a dose of 70 Gy to a head and neck tumour, whole-body dose has been shown to increase from between 0.2 Sv and 0.25 Sv for conventional therapy to nearly 2 Sv for tomotherapy; this in turn may increase the risk of radiation-induced secondary malignancies by a factor of eight [8]. The increase in MU is a function of complexity of intensity-modulation, its delivery technique and collimator design of the treatment machine. Therefore, PD needs to be measured separately for the technique employed on the treatment machine. This study was designed to measure PD from 6 MV X-rays employing static and dynamic multileaf collimation (DMLC), which is the basis for dynamic intensity-modulated radiotherapy (IMRT). Dependence of PD on out-of-field distance, strip field width, field size, direction of multileaf collimator (MLC) motion and depth of measurement were investigated.


    Methods and materials
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 References
 
Peripheral dose was measured for 6 MV X-ray using a linear accelerator (LA) (Clinac 2100 C/D; Varian Associates, Palo Alto, CA) equipped with an MLC consisting of 26 leaf pairs, each leaf projecting to a 10 mm leaf width at the isocentre distance. All measurements were carried out using a 0.6 cm3 Farmer type ionization chamber (PTW, Friedberg, Germany) inserted at 5 cm depth into a 35 cm x 35 cm x 105 cm plastic water phantom (Nuclear Associates, USA) under isocentric conditions. Field sizes of 6 cm x 6 cm, 10 cm x 10 cm and 14 cm x 14 cm defined by conventional jaws were simulated in DMLC field mode, wherein strip fields of constant width 0.5 cm, 1 cm, 1.5 cm and 2 cm created by the opposing MLCs were moved with constant speed from one bank to the other in a rectilinear fashion perpendicular to the radial axis of the LA. Thus for every open field, six sets of PDs were measured – two from static open fields shaped by jaws and MLCs and four from DMLC. When the collimator is set at 0° (IEC 61217) [9], and MLCs are used either in static or dynamic mode, the upper (Y) jaws define the superior and inferior borders and the lower (X) jaws are positioned 0.8 cm distal to the most retracted leaf position on each side of the field. The detail performance characteristic of this MLC in dynamic dose delivery has been described elsewhere [1012].

The number of MU required to deliver 1 Gy at 5 cm depth on the central axis was found by matching meter readings from the different DMLC fields to that from the corresponding, static jaw-shaped open field. These MUs were used for the subsequent PD measurement along a longitudinal axis to an out-of-field distance up to 60 cm. The factor by which planned MU increases for different DMLC fields over that of the corresponding static fields for the same dose is defined to be MU multiplication factor.

The same measurements were repeated for 10 cm x 10 cm field size with collimator at 90°, wherein the MLC executes in-plane motion. Variation in PD with depth was investigated for 10 cm and 15 cm depth under isocentric set up using 10 cm x 10 cm field size having 1 cm strip field width.


    Results
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 References
 
The MU multiplication factor for different DMLC fields was found to increase with decreasing strip field width and increasing field size (Table 1Go).


View this table:
[in this window]
[in a new window]
 
Table 1. Monitor unit(MU) multiplication factor (ratio of MU from dynamic multileaf collimation (DMLC) fields to that from correspondingopen field) for 6 MV X-ray for different DMLC fields having effective field sizes of 6 cmx6 cm, 10 cmx10 cm and 14 cmx14 cm

 
The measured PD data for 6 MV X-ray at 5 cm depth and for 0° collimator angle are shown in Figure 1Go as a function of out-of-field distance. Each family of six curves represents the PD data for jaws and MLC shaped static field and four DMLC fields having different strip field widths. The dose at the depth of maximum dose (Dmax) on the central axis of every jaws-shaped static field was normalized to 100%. All the PD data were expressed as a percentage of the respective Dmax. PD data of all DMLC fields were found to manifest two distinct regions.


Figure 1
View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Peripheral dose in phantom from 6 MV X-ray for 0° collimator and field sizes (a) 6 cm x 6 cm; (b) 14 cm x 14 cm at 5 cm depth, normalized to 100% on the central axis at depth of maximum dose of static open field. MLC, multilead collimator.

 
PD < 30 cm
The region extending up to 30 cm out-of-field distance, shows crests and troughs of varying amplitude; this is prominent for 6 cm x 6 cm (Figure 1aGo) and is found to grow progressively smaller for larger fields (Figure 1bGo).

PD > 30 cm
In this region PD curves from DMLC fields of different strip field width are seen running parallel and maintaining constant slope. The factor by which PD for different DMLC fields increase over jaws-shaped static field is observed to be almost the same as that of the corresponding increase in MU. Although the absolute value of PD is comparatively small, the percentage increase in PD is higher for this region, showing maximum increase at 60 cm out-of-field distance.

As expected, PD of all DMLC fields was found to be higher than the corresponding static open fields. For the same field size the smaller strip field width is seen delivering higher PD compared with larger strip field width. Also for the same strip field width, PD consistently increases with increasing field sizes. For 6 cm x 6 cm field, DMLC with 0.5 cm and 2 cm strip field width deliver a maximum of 8 and 2 times higher PD than that of static open fields (Figure 1aGo). The corresponding factor for 14 cm x 14 cm field is 15 and 6, respectively (Figure 1bGo). DMLC field with 0.5 cm strip field width delivers 1.5 and 3 times higher PD than that of 2 cm strip field width at 1 cm and 60 cm out-of-field distance, respectively.

As an exception, jaws-shaped static fields may deliver more PD than certain DMLC fields with larger strip field width. This exceptional phenomenon is observed for out-of-field distances extending up to 15 cm for 6 cm x 6 cm and up to 7 cm for 14 cm x 14 cm. Also, PD data of MLC shaped static field is found to be less than that of jaw-shaped static fields for out-of-field distances up to 30 cm, beyond which MLC shaped static fields show a slight increase in PD over jaws-shaped fields.

PD data for static and DMLC fields measured with 90° collimation shows a reduction in value compared with data measured with 0° collimation. The magnitude of reduction is seen to depend on out-of-field distance and strip field width. For 10 cm x 10 cm field, maximum reduction in PD data for jaws and MLC shaped static field are found to be by a factor of 2 and 2.5, respectively (Figure 2Go). For DMLC fields, a maximum reduction factor of 3 is observed at 30 cm out-of-field distance for the smallest strip field width of 0.5 cm (Figure 3Go). Similar characteristics were observed for larger strip field widths, albeit with progressively lower PD. MLC shaped static and DMLC fields show no change in PD at 20 cm from the field edge for these two collimator orientations.


Figure 2
View larger version (21K):
[in this window]
[in a new window]
 
Figure 2. Composite peripheral dose(PD) distribution of 6 MV X-ray measured at 5 cm depth with 0° and 90° collimator angle from 10 cm x 10 cm static field shaped by jaws and multileaf collimator (MLC), normalized to 100% on the central axis at depth of maximum dose of static open field.

 

Figure 3
View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Composite peripheral dose(PD) distribution of 6 MV X-ray measured at 5 cm depth with 0° and 90° collimator angles from 10 cm x 10 cm field simulated in dynamic multileaf collimation (DMLC) mode using 0.5 cm sweeping gap width, normalized to 100% on the central axis at depth of maximum dose of static open field.

 
PD measured under isocentric condition at 5 cm, 10 cm and 15 cm depth using 10 cm x 10 cm fields and 1 cm strip field width are shown in Figure 4Go. A maximum reduction of 20% and 40% at 60 cm from the field edge is observed for 10 cm and 15 cm depth, respectively, as compared with the data measured at 5 cm depth.


Figure 4
View larger version (19K):
[in this window]
[in a new window]
 
Figure 4. Peripheral dose(PD) in phantom from 6 MV X-rays measured at 5 cm, 10 cm and 15 cm depth with target to chamber distance of 100 cm. Effective field size of 10 cm x 10 cm having 1 cm sweeping gap width and 0° collimator is used. PD is normalized to 100% on the central axis at depth of maximum dose of static open field.

 

    Discussion
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 References
 
Pre-measured PD data from static fields [1, 2, 1317], and an empirical relationship [18], are available as a guideline to evaluate approximate out-of-field organ dose from conventional treatment. The qualitative and quantitative behaviour of our jaw-shaped open field (10 cm x 10 cm, 0° collimation and 5 cm depth) PD data is in agreement with other findings [2, 17]. But beyond 30 cm out-of field distance, our PD data for MLC shaped static field disagrees with that of Mutic et al [17] who have reported reduction in PD at all out-of-field distances. However, when the collimator is rotated to 90° our data agrees with the findings of Mutic et al [17].

Although IMRT offers significant advantages for dose conformality to irregular target volumes with sharp dose gradient beyond the target, it also increases MU/Gy and hence whole body dose. This may be a concern for long-term radiation sequelae in patients treated with this technique [8, 19]. Whole-body dose data are available from tomotherapy [58]. However, the same data cannot be applied to sliding window IMRT technique as the collimator scatter and transmission, head leakage and internal scatter, which are the main components of PD, depend on the collimator design of treatment machine and beam delivery technique. Our study was carried out to find PD from different DMLC fields which closely simulated sliding window IMRT. When static fields are simulated in DMLC mode, PD was found to increase by a factor of 2 to 15, similar to the increase in MU for DMLC fields over corresponding static open fields. Increase in MU due to the use of a universal wedge have also shown to increase PD by a factor of 2–4 compared with PD resulting from unwedged beam [1416].

Even though the intensity of radiation is not modulated in our dynamic fields, different strip field width can be thought to represent the different complexity of intensity profile required in IMRT. As the degree of modulation increases, i.e. peaks and valleys in the intensity profile are sought to be closely spaced, these highly modulated beams require narrow MLC openings leading to sharp increase in MU. With sliding window IMRT, higher MU becomes an absolute corollary and the planned MU tends to be larger in cases where the fluence distribution is more modulated.

Even though PD from DMLC field is generally observed to be more than that of jaw-shaped static field, a slight reduction in PD is observed near the field edge for DMLC field with larger sweeping gap width. This may be attributed to reduction in collimator scatter and transmission of DMLC fields offered by the stationary portion of the MLC. The increase in MU for smaller sweeping gap widths for the same field and dose, increases both scatter and leakage dose leading to the increase in PD.

Besides internal scatter and leakage dose, PD in the proximal region (5–30 cm) seems to be a complex interplay of leaf scatter, leaf end design, MLC placement in treatment head, MLC motion and beam-on time. Similar to our crest and trough effect appearing within 30 cm of the field edge, Greene et al [20] have reported a sharp peak at 20 cm from the edge of 10 cm x 10 cm field due to maximum scatter coming from the face of the beam-defining jaws, which disappears for large field sizes as the point that sees maximum scatter from the face of the jaws shifts into the primary beam itself. In our case, this situation never realises completely, even for large DMLC fields, probably because scatter radiation arises both from the face of jaws and from the rounded end face of the sweeping MLCs.

The crest and trough effect appearing prominently for smaller dynamic fields may be clinically significant especially when a critical organ is lying close to the primary field. If an organ at risk is lying at the distance of 15 cm from the field edge (field size 6 cm x 6 cm) it would received 4.5 times more dose than the case where this effect is not taken into account. Moreover, it is not known if commercially available treatment planning systems take into account this pattern of PD during optimization and dose computation. Further study is required to segregate the different components of scatter and leakage. Inclusion of PD characteristics in dose calculation algorithms is suggested.

Most published data for static field shows small variation in PD with depth of measurement [1, 2, 15]. However, similar to the finding of Tatcher et al, our measurement for DMLC field shows decrease in PD with depth of measurement.

The largest field studied is 14 cm x 14 cm as limited by the maximum range of travel of individual leaves relative to the carriage. While normalizing the dose at depth of dose maximum to 100%, central axis depth dose characteristics of the DMLC field of a particular size is assumed to remain same as that for a static field. The uncertainty associated with low dose measurement especially at 60 cm with lower MU generally for the static fields are not considered in the presented data. For open fields where the MU is small, MU was scaled by a factor of 2–3 to get good signal at largest out-of-field distance. The reproducibility of meter reading for DMLC fields was observed to be less than 2% during the measurement.

As the IMRT field employed in the clinical situations consists of a mixture of multiple strip fields having different gap width (beamlet size), validation of the phantom measured PD from uniform DMLC field needs to be carried out using the clinically employed fluence.

Received for publication June 16, 2004. Revision received May 31, 2005. Accepted for publication July 19, 2005.


    References
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 References
 

  1. Fraass BA, van de Geijn J. Peripheral dose from megavoltage beams. Med Phys 1983;10:809–18.[CrossRef][Medline]
  2. Stovall M, Blackwell CR, Cundiff J, Novack DH, Palta JR, Wagner LK, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Task Group No. 36. Med Phys 1995;22:63–82
  3. Sneed PK, Albright NW, Wara WM, Prados MD, Wilson CB. Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys 1995;32:823–30.[CrossRef][Medline]
  4. Sharma DS, Rakesh J, Tambe CM, Animesh, Deshpande DD. Effect of tertiary multileaf collimator (MLC) on foetal dose during three-dimensional conformal radiation therapy (3DCRT) of a brain tumour during pregnancy. Radiother Oncol 2004;70:49–54.[Medline]
  5. Followill D, Geis P, Boyer A. Estimates of whole-body equivalent dose produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997;38:667–72.[Medline]
  6. Mutic S, Low DA. Whole-body dose from tomotherapy delivery. Int J Radiat Oncol Biol Phys 1998;42:229–32.[Medline]
  7. Meeks SL, Paulino AC, Pennington EC, Simon JH, Skwarchuk MW, Buatti JM. In vivo determination of extra-target doses received from serial tomotherapy. Radiother Oncol 2002;63:217–22.[Medline]
  8. Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199–203.[Medline]
  9. International Electrotechnical Commission, IEC Report 61217: Radiotherapy Equipment – Co-ordinates, Movements and Scales. IEC, Geneva, Switzerland, 1997
  10. Chui CS, Spirou S, LoSasso T. Testing of dynamic multileaf collimation. Med Phys 1996;23:635–41.[Medline]
  11. LoSasso T, Chui CS, Ling C. Physics and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys 1998;25:1919–27.[Medline]
  12. Low DA, Sohn JW, Klein EE, Markman J, Mutic S, Dempsey J. Characterization of a commercial multileaf collimator used for intensity modulated radiation therapy. Med Phys 2001;28:752–6.[Medline]
  13. Greene D, Chu GL, Thomas DW, Taylor RJ. Dose levels outside radiotherapy beams. Br J Radiol 1983;56:543–50.[Abstract]
  14. Sherazi S, Kase KR. Measurements of dose from secondary radiation outside a treatment field: effects of wedges and blocks. Int J Radiat Oncol Biol Phys 1985. 11:2171–6.
  15. McParland BJ. Peripheral dose of two linear accelerators employing universal wedges. Br J Radiol 1990;63:295–8.[Medline]
  16. Mutic S, Esthappan J, Klein EE. Peripheral dose distributions for a linear accelerator equipped with a secondary multileaf collimator and universal wedge. J Appl Clin Med Phys 2002;3:302–9.[Medline]
  17. Mutic S, Klein EE. A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation. Int J Radiat Oncol Biol Phys 1999;44:947–53.[Medline]
  18. Mazonakis M, Damilakis J, Varveris H, Theoharopoulos N, Gourtsoyiannis N. A method of estimating fetal dose during brain radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:455–9.[CrossRef][Medline]
  19. Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3DCRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83–8.[CrossRef][Medline]
  20. Greene D, Karup PGG, Sims C, Taylor RJ. Dose levels outside radiotherapy beams. Br J Radiol 1985;58:453–6.[Medline]




This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, D S
Right arrow Articles by Dinshaw, K A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, D S
Right arrow Articles by Dinshaw, K A


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS